John G. Singer 2/17/25 John G. Singer 2/17/25 The Massive Grapple Ahead for Pharma Read More John G. Singer 2/13/25 John G. Singer 2/13/25 How to Sell AI in the Kingdom of the Bored Read More John G. Singer 2/6/25 John G. Singer 2/6/25 Whatever Happened to Eisai’s “Dementia Ecosystem”? Read More John G. Singer 1/31/25 John G. Singer 1/31/25 Should Eli Lilly Acquire Walgreens? Should Novo Nordisk? Read More John G. Singer 1/29/25 John G. Singer 1/29/25 Houston, We Need a New Narrative Read More John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More John G. Singer 1/16/25 John G. Singer 1/16/25 The Keystone Advantage for Pharma Read More John G. Singer 12/29/24 John G. Singer 12/29/24 The S&P 493 Has Run Out of Ideas Read More Newer Posts Older Posts
John G. Singer 2/6/25 John G. Singer 2/6/25 Whatever Happened to Eisai’s “Dementia Ecosystem”? Read More
John G. Singer 1/31/25 John G. Singer 1/31/25 Should Eli Lilly Acquire Walgreens? Should Novo Nordisk? Read More
John G. Singer 1/25/25 John G. Singer 1/25/25 Amazon, LillyDirect and Big Market Innovation Read More
